Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Anticancer Research
|
August 8, 2009
Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité
Sebastian Ochsenreither, Simone Marnitz-Schultze, Achim Schneider, et al.
Laryngo- Rhino- Otologie
|
May 12, 2017
[Immunotherapy Against Head and Neck Cancer Stem Cells]
Annekatrin Coordes, Sebastian Ochsenreither, Xu Qian, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens
Paul Schossig, Ebru Coskun, Ruza Arsenic, et al.
Cancer & Metabolism
|
October 2, 2025
Pressure-adjusted static compression: aerobic metabolism and microvascular perfusion in the context of chemotherapy-induced neuropathy
Betty Lischke, Josef Mohammad, René Rheimann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2010
Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells
Antonia Busse, AnneMarie Asemissen, Anika Nonnenmacher, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2021
Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
Anja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
Cancer Immunology, Immunotherapy : CII
|
March 12, 2020
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
Anja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
Antonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Annals of Hematology
|
October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
The Laryngoscope
|
March 18, 2021
Carcinoma of Unknown Primary and the 8th Edition TNM Classification for Head and Neck Cancer
Robert Boeker, Carmen Stromberger, Max Heiland, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Anticancer Research
|
August 8, 2009
Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité
Sebastian Ochsenreither, Simone Marnitz-Schultze, Achim Schneider, et al.
Laryngo- Rhino- Otologie
|
May 12, 2017
[Immunotherapy Against Head and Neck Cancer Stem Cells]
Annekatrin Coordes, Sebastian Ochsenreither, Xu Qian, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens
Paul Schossig, Ebru Coskun, Ruza Arsenic, et al.
Cancer & Metabolism
|
October 2, 2025
Pressure-adjusted static compression: aerobic metabolism and microvascular perfusion in the context of chemotherapy-induced neuropathy
Betty Lischke, Josef Mohammad, René Rheimann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2010
Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells
Antonia Busse, AnneMarie Asemissen, Anika Nonnenmacher, et al.
Cancer Immunology, Immunotherapy : CII
|
June 25, 2021
Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
Anja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
Cancer Immunology, Immunotherapy : CII
|
March 12, 2020
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
Anja Tatjana Teck, Sabrina Urban, Petra Quass, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
Antonia Busse, Anne Marie Asemissen, Anika Nonnenmacher, et al.
Annals of Hematology
|
October 14, 2014
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
Stephan Kreher, Sebastian Ochsenreither, Ralf U Trappe, et al.
The Laryngoscope
|
March 18, 2021
Carcinoma of Unknown Primary and the 8th Edition TNM Classification for Head and Neck Cancer
Robert Boeker, Carmen Stromberger, Max Heiland, et al.
Page
of 8